AUTHORS: Ella Odams, Richard Sloggett, Graham Foxon OBJECTIVES To evaluate if ChatGPT is a rel...
Read moreThis study investigates the capabilities of AI tools including ChatGPT for conducting pricing and re...
Read moreArticle originally published 11th August 2022, updated 18th June 2024. Introduction Digital health a...
Read moreArticle originally published 17th August 2022, updated 11th June 2024. Introduction Artificial intel...
Read moreArtificial intelligence is set to revolutionise the market access and healthcare landscape, but huma...
Read moreThe World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar...
Read moreOur experts provide an overview of the five key trends that could shape the pricing and market acces...
Read moreBack in January this year, we summarised the key trends our market access experts believed would dom...
Read moreOur study compares and contrasts the evaluation and reimbursement pathways for digital therapeutics ...
Read moreWe explore the rapidly evolving market access landscape in respect to digital health applications in...
Read more